
Vol. 35, No. 1, 2003
Free Abstract Article (References)
Article (PDF 114 KB)
Short Communication
Treatment of Rubeosis iridis with Photodynamic Therapy with Verteporfin – A New Therapeutic and Prophylactic Option for Patients with the Risk of Neovascular Glaucoma?
Valeska A. Müller, Peter Ruokonen, Meike Schellenbeck, Christian Hartmann, Manfred Tetz
Department of Ophthalmology, Charité Campus Virchow, Humboldt University, Berlin, Germany
Address of Corresponding Author
Ophthalmic Res 2003;35:60-64 (DOI: 10.1159/000068195)
Key Words
- Anterior segment neovasculature
- Photodynamic therapy
- Rubeosis iridis
Abstract
Patients with ischaemic retinopathy who show iris neovascularization despite panretinal laser photocoagulation (PRP) very often develop a neovascular glaucoma. Photodynamic therapy (PDT) has been shown to occlude neovascularization without damage to physiologic vessels or adjacent tissue in the treatment of choroidal neovascularization (CNV) and might also be of value for patients with neovascular glaucoma who did not benefit from the PRP. First results of a monocentre, open label, intra-individual controlled, pilot phase I/II, dose-finding study demonstrate that PDT with verteporfin is capable of occluding neovascular vessels for a defined period of time without damaging adjacent tissue or physiologic iris vessels. Whether this vessel occlusion will have an impact on the progression of rubeosis or neovascular glaucoma will be the subject of further investigation. Copyright © 2003 S. Karger AG, Basel
Author Contacts
Dr. Valeska Anja Müller Department of Ophthalmology, Charité Klinikum Campus Virchow, Augustenburger Platz 1 D–13353 Berlin (Germany) Tel. +49 30 450 554202, Fax +49 30 450 554900, E-Mail valeska_mueller@hotmail.com
Article Information
Received: Received: April 14, 2002
Accepted after revision: September 16, 2002
Number of Figures : 1, Number of Tables : 1, Number of References : 22 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|